tiprankstipranks
Trending News
More News >

Ideaya Biosciences granted breakthrough therapy designation for darovasertib

Ideaya Biosciences (IDYA) announced that the FDA has granted breakthrough therapy designation for darovasertib, a protein kinase C inhibitor, for the neoadjuvant treatment of adult patients with primary uveal melanoma for whom enucleation has been recommended.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue